FDA panel approved Astellas’s drug for invasive fungal infection, a new blood cancers drug

January 24, 2015 7:17 PM

4 0

FDA panel approved Astellas’s drug for invasive fungal infection, a new blood cancers drug

Manufactured by Astellas Pharma Inc., a panel of regulators has voted for the approval of a new drug that treats invasive aspergillosis – an often fatal invasive fungal infection that targets blood cancer patients.

The new drug is manufactured by a Japanese drugmaker and after sufficiently proven for safety and efficacy, it is now being voted to be approved by the US Food and Drug Administration (FDA) for use within the United States.

Read more

To category page

Loading...